NEWTON SQUARE, Pa. — The Homeopathic Pharmacopoeia Convention for the United States (HPCUS) “Service to Homeopathy Award” was recently presented to Mark Land of Boiron USA  in recognition of his many years of volunteer service to the community and in honor of his 40th anniversary in the homeopathic industry. The HPCUS sets the standard for the quality and safety of homeopathic drugs in the United States. HPCUS president J.P. Borneman, presented the award virtually at the HPCUS Annual Membership Meeting originally scheduled in McLean, Virginia, on Sunday, April 19, 2020.

Mark Land

Land is the vice president of government and regulatory affairs at Boiron USA. Earlier in the year, the company hosted a celebration to celebrate his 40 years with the French-based homeopathic manufacturer. At the HPCUS, Land volunteers as the chairman of the Monograph Review Committee. He developed a systematic mechanism for the review of technical information submitted in support of new monographs for the HPUS. He has also made significant contributions to the HPCUS Standards and Controls Committee by providing countless translations of technical documents related to quality control tests.

Land joined the HPCUS in 2002. In his remarks, HPCUS president Borneman noted Land’s long and significant service to the homeopathic community, “The HPCUS has valued Mark’s service for decades. His approach to modernizing monograph review is but one of his many achievements. Mark’s leadership at AAHP has propelled the industry forward, and we are all better for his efforts.”

In his other volunteer position, Land serves as the president of the American Association of Homeopathic Pharmacists (AAHP), which represents the manufacturers of homeopathic medicines and takes the lead in representing the homeopathic community to the national regulators and legislators in Washington D.C. First assisting AAHP as a board member in 2004, he has served as the organization’s volunteer president for 14 years. Last summer Mark organized an industrywide and international Summit to further develop quality manufacturing and regulatory compliance to improve the products and safety profile of homeopathic drugs distributed in the U.S. The event attracted more than 100 participants from five countries and significantly opened a dialog between the manufacturing industry and the U.S. Food and Drug Administration.

“I believe that the professional and commercial success of homeopathic manufacturers rests in our collective ability to proactively adapt to the requests of our clients, the needs of physicians and the demands of regulators,” said Land in accepting the award and challenged industry leaders to inspire and mentor the next generation of leaders in the homeopathic community.